Bridger Management, LLC Apellis Pharmaceuticals, Inc. Transaction History

Bridger Management, LLC

  • $196 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$31.4 - $69.84 $3.64 Million - $8.1 Million
-116,015 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$40.9 - $64.9 $8.51 Million - $13.5 Million
-207,985 Reduced 64.19%
116,015 $7.33 Million
Q1 2021

May 14, 2021
BUY
$40.8 - $57.39 $13.2 Million - $18.6 Million
324,000 New
324,000 $13.9 Million

Others Institutions Holding APLS

# of Institutions
308
Shares Held
115M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.65B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Bridger Management, LLC Portfolio

Follow Bridger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email